Literature DB >> 9916733

IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis.

M Matsumoto1, C Ra, K Kawamoto, H Sato, A Itakura, J Sawada, H Ushio, H Suto, K Mitsuishi, Y Hikasa, H Matsuda.   

Abstract

IgE hyperproduction frequently observed in patients with atopic dermatitis (AD) may greatly contribute to the pathogenesis of AD, but its mechanisms are still unclear. NC/Nga mice raised in nonsterile circumstances spontaneously suffered from AD-like skin lesions with elevation of plasma IgE levels. We investigated mechanisms of the IgE hyperproduction in NC/Nga mice. Splenic T cells from SPF NC/Nga mice had a level of CD40 ligand (CD40L) expression comparable to that of BALB/c mice. Although there was no difference in the expression of CD40 on B cells between NC/Nga and BALB/c mice, B cells of NC/Nga mice produced much more IgE in the presence of soluble CD40L and IL-4. The stimulation with CD40L and/or IL-4 resulted in tyrosine phosphorylation of Janus kinase 3 (JAK3) in B cells, which was more strongly inducible in NC/Nga mice than in BALB/c mice. In B cells isolated from PBMC of AD patients with high serum IgE levels, JAK3 was constitutively phosphorylated at the tyrosine residue, and its phosphorylation was enhanced by the treatment with CD40L and/or IL-4 as was that in splenic B cells of NC/Nga mice with dermatitis and high IgE levels. Thus, it is suggested that constitutive and enhanced JAK3 phosphorylation in B cells highly sensitive to CD40L and IL-4 may be attributable to IgE hyperproduction in NC/Nga mice and patients with AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916733

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Pulmonary effects of diesel exhaust: neutrophilic inflammation, oxidative injury, and asthma.

Authors:  Nicholas Kenyon; Fu-Tong Liu
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

Review 2.  Janus kinase-3 dependent inflammatory responses in allergic asthma.

Authors:  Rama Malaviya; Debra L Laskin; Ravi Malaviya
Journal:  Int Immunopharmacol       Date:  2010-04-27       Impact factor: 4.932

3.  Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A.

Authors:  Tae-Young Lee; Doo-Jin Kim; Ji-Na Won; Il-Han Lee; Moon-Hee Sung; Haryoung Poo
Journal:  J Invest Dermatol       Date:  2013-09-11       Impact factor: 8.551

Review 4.  Lessons from murine models of atopic dermatitis.

Authors:  Tao Zheng; Zhou Zhu
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.806

5.  Oral administration of Vaccinium uliginosum L. extract alleviates DNCB-induced atopic dermatitis in NC/Nga mice.

Authors:  Kang-Hyun Kim; Se-Young Choung
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

6.  Canine epidermal langerhans cells express alpha and gamma but not beta chains of high-affinity IgE receptor.

Authors:  M Bonkobara; F Miyake; H Yagihara; O Yamada; D Azakami; T Washizu; P D Cruz; K Ariizumi
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

7.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 8.  Animal models of atopic dermatitis.

Authors:  Haoli Jin; Rui He; Michiko Oyoshi; Raif S Geha
Journal:  J Invest Dermatol       Date:  2009-01       Impact factor: 8.551

9.  Effect of German chamomile oil application on alleviating atopic dermatitis-like immune alterations in mice.

Authors:  Soon-Hee Lee; Yong Heo; Young-Chul Kim
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.603

Review 10.  Mast cells in atopic dermatitis.

Authors:  Toshiaki Kawakami; Tomoaki Ando; Miho Kimura; Bridget S Wilson; Yuko Kawakami
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.